Название документа

Inzhesta is hormones of gonads. Gestagena. The indications

Disturbance connected with deficiency of progesterone.

Oral administration

Gynecologic: the violations connected with deficiency of progesterone namely:

  • premenstrual syndrome;
  • violation of a menstrual cycle (dizovulyatsiya, anovulyatsiya).

Obstetric:

  • prevention of a usual abortion or threat of an abortion against the background of lyuteinovy insufficiency;
  • threat of premature births.
Structure
  • 1 capsule contains

    progesterone micronized 200 mg;

  • excipients: lecithin, sunflower oil;
  • structure of a cover of the capsule: gelatin, glycerin, titan dioxide (E 171).

Contraindication

Hypersensitivity to medicine components.

Heavy abnormal liver functions.

Suspect or is confirmed to

a neoplasia of a breast or genitals.

not diagnosed vaginal bleedings.

Unsuccessful or incomplete abortion.

Thrombophlebitis. Thromboembolic violations.

Cerebral hemorrhage.

Porphyria.

Route of administration

Oral administration

In most cases the average daily dose makes 200-300 mg in 1 or 2 receptions (200 mg in the evening, before going to bed, and 100 mg in the morning if there is such need).

Capsule to enter Intravaginalnoye's

application

deeply into a vagina in a dorsal decubitus.

Before each use of medicine needs to wash up carefully hands that there is no detergent left on hands.

dose averages 200 mg of progesterone a day (1 capsule on 200 mg or 2 capsules on 100 mg, in 2 receptions, in the morning and in the evening which enter deeply into a vagina, if necessary - by means of the applicator). The dose can be increased depending on reaction of the patient.

At partial insufficiency of a lyuteinovy phase (dizovulyatsiya, violation of a menstrual cycle) the daily dose makes 200 mg within 10 days (usually from the 17th to the twenty sixth day of a cycle).

Feature of application

Treatment in the recommended doses has no contraceptive effect.

If the course of treatment begins

very much early - at the beginning of a monthly cycle, especially till 15th day of a cycle, reduction of a cycle or bleeding can be observed.

in case of uterine bleedings not to appoint medicine without specification of their reason, in particular at endometrium inspection.

Pregnant to

Use of the medicine Inzhesta® is not contraindicated to

at pregnancy, including in the first weeks

Children

Clinical data on use of medicine to children are absent.

Drivers

drowsiness and dizziness Is possible

.

Overdose

Symptoms of overdose can be shown by symptomatology of side reactions, including drowsiness, dizziness, euphoria, a dysmenorrhea, reduction of duration of a cycle, a metrorrhagia.

Side effects

from a reproductive system and mammary glands: change of periods, an amenorrhea, the alternating bleedings.

from nervous system: drowsiness, short-term feeling of dizziness.

from digestive system: vomiting, diarrhea, lock.

Storage conditions

to Store

at a temperature not above 25 °C.

to Store

out of children's reach.

Characteristics
Active ingredients Progesterone
Amount of active ingredient 200 mg
Applicant Pharmak
Code of automatic telephone exchange G03DA04 Progesterone
Interaction with food Later
Light sensitivity Not sensitive
Market status The branded generic
Origin Chemical
Prescription status According to the prescription
Primary packing box
Producer PUBLIC JOINT STOCK COMPANY PHARMAK
Quantity in packing 20 capsules
Release form capsules for internal use
Route of administration Oral
Sign Domestic
Storage temperature from 5 °C to 25 °C
Trade name Inzhesta

Reviews Inzhesta kaps. soft 200 mg No. 20

5 Rating 1 Reviews

Quality
Speed
Delivery
Performance
Price

Inzhesta kaps. soft 200 mg No. 20

  • Product Code: 180000
  • In Stock

  • Ready to ship
  • $43.86


Related Products

Last Viewed

Модули для Opencart